FDA Grants Accelerated Approval for OTOF Gene Therapy - Quiz - MDSpire

FDA Grants Accelerated Approval for OTOF Gene Therapy

A one-time intracochlear gene therapy improved hearing outcomes in patients with OTOF-related sensorineural hearing loss in the phase 1/2 CHORD trial.

  • By

  • Kathryn Wighton

  • April 23, 2026

  • 3 min

Share

Original Source(s)

FDA Grants Accelerated Approval for OTOF Gene Therapy

  • by Kathryn Wighton

  • April 23, 2026

Related Content

Medical Oddities: Something Viral is Lurking in the Dust

Everyday things like yawns, tea, dust, and kimchi suddenly look medically important.

Upper Lip Frenulum Findings and Breastfeeding Problems in Healthy Newborns

Objective oculomotor, vestibular, reaction time, and cognitive signatures of vestibular migraine